$27.46 1.3%
BBIO Stock Price vs. AI Score (Last 150 days)
Data gathered: July 15

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About BridgeBio Pharma

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development.

BridgeBio Pharma
Price $27.46
Target Price Sign up
Volume 129,650
Market Cap $5.07B
Year Range $23 - $43.89
Dividend Yield 0%
Revenue per Employee $305,661
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24169M600,000169M-35M-11M-0.200
Q4 '231.7M600,000-20M-168M-284M-0.960
Q3 '234.1M600,000-17M-177M-156M-1.080
Q2 '231.6M600,000-18M-158M-137M-0.980
Q1 '231.8M650,000-49M-140M-119M-0.920

Insider Transactions View All

Scott Randal W. filed to sell 4,000 shares at $31.3.
June 5 '24
Scott Randal W. filed to sell 5,500 shares at $29.5.
June 5 '24
Scott Randal W. filed to sell 5,700 shares at $28.7.
June 5 '24
Scott Randal W. filed to sell 6,500 shares at $34.
March 5 '24
Valantine Hannah filed to sell 1,764 shares at $37.8.
February 20 '24

What is the Market Cap of BridgeBio Pharma?

The Market Cap of BridgeBio Pharma is $5.07B.

How Many People Work at BridgeBio Pharma?

As of our latest update, BridgeBio Pharma employed approximately 578 people worldwide. However, it's important to note that BridgeBio Pharma's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is BridgeBio Pharma's revenue per employee?

$305,661. To calculate BridgeBio Pharma's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of BridgeBio Pharma?

Currently, the price of one share of BridgeBio Pharma stock is $27.46.

How can I analyze the BBIO stock price chart for investment decisions?

The BBIO stock price chart above provides a comprehensive visual representation of BridgeBio Pharma's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling BridgeBio Pharma shares. Our platform offers an up-to-date BBIO stock price chart, along with technical data analysis and alternative data insights.

Does BBIO offer dividends to its shareholders?

As of our latest update, BridgeBio Pharma (BBIO) does not offer dividends to its shareholders. Investors interested in BridgeBio Pharma should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of BridgeBio Pharma?

Some of the similar stocks of BridgeBio Pharma are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.